Denis Poddubnyy1,2, Joachim Listing2, Hildrun Haibel1, Sven Knüppel3,4, Martin Rudwaleit1,5, Joachim Sieper1. 1. Department of Gastroenterology, Infectiology and Rheumatology, Campus Benjamin Franklin, Charité Universitätsmedizin Berlin. 2. Department of Epidemiology, German Rheumatism Research Centre, Berlin. 3. Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal. 4. Institute of Public Health, Charité Universitätsmedizin Berlin, Berlin. 5. Department of Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany.
Abstract
Objectives: The aim of the study was to investigate the functional relevance of the development of structural damage in the spine in patients with early axial spondyloarthritis (axSpA). Methods: Altogether, 210 patients with early axSpA (symptom duration ⩽10 years) who completed a 2-year clinical and radiographic follow-up in the GErman SPondyloarthritis Inception Cohort were included. An association between structural damage in the spine [modified Stoke AS Spine Score (mSASSS)] and functional status (the BASFI) or spinal mobility (the BASMI) was assessed in a longitudinal linear mixed model analysis; both unstandardized (β) and standardized (βstand) regression coefficients were calculated. Results: There was an association between mSASSS and BASFI: β = 0.05 (95% CI: 0.03, 0.08) and βstand = 0.20 (95% CI: 0.11, 0.59) adjusted for disease activity parameters (the BASDAI and CRP), the presence of definite radiographic sacroiliitis and sex. An association between mSASSS and BASMI was stronger: β = 0.08 (95% CI: 0.05, 0.11) and βstand = 0.41 (95% CI: 0.25, 0.57) adjusted for the same parameters. These data indicate that, over time, an increase of 20 or 12 mSASSS points would be responsible for an increase of one BASFI or one BASMI point, respectively. Disease activity (BASDAI) also showed a significant association with BASFI [β = 0.79 (95% CI: 0.71, 0.86) and βstand = 0.71 (95% CI: 0.63, 0.77)] and BASMI [β = 0.22 (95% CI: 0.15, 0.30) and βstand = 0.28 (95% CI: 0.18, 0.37)]. Conclusion: Structural damage in the spine and disease activity are both determinants of the functional status and spinal mobility in early axSpA.
Objectives: The aim of the study was to investigate the functional relevance of the development of structural damage in the spine in patients with early axial spondyloarthritis (axSpA). Methods: Altogether, 210 patients with early axSpA (symptom duration ⩽10 years) who completed a 2-year clinical and radiographic follow-up in the GErman SPondyloarthritis Inception Cohort were included. An association between structural damage in the spine [modified Stoke AS Spine Score (mSASSS)] and functional status (the BASFI) or spinal mobility (the BASMI) was assessed in a longitudinal linear mixed model analysis; both unstandardized (β) and standardized (βstand) regression coefficients were calculated. Results: There was an association between mSASSS and BASFI: β = 0.05 (95% CI: 0.03, 0.08) and βstand = 0.20 (95% CI: 0.11, 0.59) adjusted for disease activity parameters (the BASDAI and CRP), the presence of definite radiographic sacroiliitis and sex. An association between mSASSS and BASMI was stronger: β = 0.08 (95% CI: 0.05, 0.11) and βstand = 0.41 (95% CI: 0.25, 0.57) adjusted for the same parameters. These data indicate that, over time, an increase of 20 or 12 mSASSS points would be responsible for an increase of one BASFI or one BASMI point, respectively. Disease activity (BASDAI) also showed a significant association with BASFI [β = 0.79 (95% CI: 0.71, 0.86) and βstand = 0.71 (95% CI: 0.63, 0.77)] and BASMI [β = 0.22 (95% CI: 0.15, 0.30) and βstand = 0.28 (95% CI: 0.18, 0.37)]. Conclusion:Structural damage in the spine and disease activity are both determinants of the functional status and spinal mobility in early axSpA.
Authors: H Haibel; I Redeker; A Zink; J Callhoff; U Marschall; F Hoffmann; J Sieper; D Poddubnyy Journal: Z Rheumatol Date: 2019-11 Impact factor: 1.372
Authors: Mark C Hwang; MinJae Lee; Lianne S Gensler; Matthew A Brown; Amirali Tahanan; Mohammad H Rahbar; Theresa Hunter; Mingyan Shan; Mariko L Ishimori; John D Reveille; Michael H Weisman; Thomas J Learch Journal: Rheumatology (Oxford) Date: 2022-05-05 Impact factor: 7.046
Authors: Paras Karmacharya; Ali Duarte-Garcia; Maureen Dubreuil; M Hassan Murad; Ravi Shahukhal; Pragya Shrestha; Elena Myasoedova; Cynthia S Crowson; Kerry Wright; John M Davis Journal: Arthritis Rheumatol Date: 2020-04-01 Impact factor: 10.995
Authors: Ennio Lubrano; Fabio Massimo Perrotta; Maria Manara; Salvatore D'Angelo; Roberta Ramonda; Leonardo Punzi; Olga Addimanda; Carlo Salvarani; Antonio Marchesoni Journal: Rheumatol Ther Date: 2020-02-15